Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Frontiers in Pharmacology
Muthu K ShanmugamAlan Prem Kumar

Abstract

Several lines of evidence have demonstrated that deregulated activation of NF-κB plays a pivotal role in the initiation and progression of a variety of cancers including multiple myeloma (MM). Therefore, novel molecules that can effectively suppress deregulated NF-κB upregulation can potentially reduce MM growth. In this study, the effect of celastrol (CSL) on patient derived CD138+ MM cell proliferation, apoptosis, cell invasion, and migration was investigated. In addition, we studied whether CSL can potentiate the apoptotic effect of bortezomib, a proteasome inhibitor in MM cells and in a xenograft mouse model. We found that CSL significantly reduced cell proliferation and enhanced apoptosis when used in combination with bortezomib and upregulated caspase-3 in these cells. CSL also inhibited invasion and migration of MM cells through the suppression of constitutive NF-κB activation and expression of downstream gene products such as CXCR4 and MMP-9. Moreover, CSL when administered either alone or in combination with bortezomib inhibited MM tumor growth and decreased serum IL-6 and TNF-α levels. Overall, our results suggest that CSL can abrogate MM growth both in vitro and in vivo and may serve as a useful pharmacological agent...Continue Reading

References

Dec 3, 1999·British Journal of Haematology·D PuthierM Amiot
Feb 19, 2000·Rheumatic Diseases Clinics of North America·X Tao, P E Lipsky
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Nicholas MitsiadesKenneth C Anderson
Nov 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G David Roodman
Apr 20, 2004·Blood·Teru HideshimaKenneth C Anderson
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Oct 22, 2005·Leukemia·N W C J van de DonkA C Bloem
Aug 19, 2007·Cancer Cell·Jonathan J KeatsP Leif Bergsagel
Aug 19, 2008·Molecular Cancer Research : MCR·Stephanie MarkovinaShigeki Miyamoto
Feb 24, 2009·Chemistry & Biodiversity·Xiao-Hui SuHiromasa Kiyota
Jun 23, 2009·Lancet·Marc S RaabKenneth C Anderson
Jan 8, 2010·Blood·Yulia N DemchenkoW Michael Kuehl
Jan 26, 2010·Cancer Chemotherapy and Pharmacology·Scott AcklerAlexander R Shoemaker
Oct 5, 2010·Oncotarget·Yulia N Demchenko, W Michael Kuehl
Jan 26, 2011·Annual Review of Pathology·Kenneth C Anderson, Ruben D Carrasco
May 1, 2012·Critical Reviews in Oncology/hematology·Darío GalmariniFelipe C Galmarini
May 31, 2012·Blood·Philippe MoreauJean-Luc Harousseau
Jun 26, 2012·Blood·Antonio Palumbo, Federica Cavallo
Jan 8, 2013·Japanese Journal of Clinical Oncology·Kenshi Suzuki
Jan 24, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Shun-Fa YangDan-Ning Hu
Jun 28, 2014·BioMed Research International·Chih-Hsin TangPo-Lin Kuo
Jan 7, 2015·Journal of Cancer·Artur JurczyszynMarcin Majka
Feb 19, 2015·Archives of Toxicology·Feng LiGautam Sethi
Apr 18, 2015·BioMed Research International·Yih-Shou HsiehDan-Ning Hu

❮ Previous
Next ❯

Citations

Feb 6, 2019·International Journal of Molecular Sciences·Vaishali AggarwalMukerrem Betul Yerer
Feb 23, 2019·Cancers·Bethsebie Lalduhsaki SailoAjaikumar Bahulayan Kunnumakkara
May 6, 2019·Cancers·Samantha Kah Ling OngAnupam Bishayee
Feb 12, 2020·International Journal of Molecular Sciences·Hong WangFeng Ru Tang
Mar 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shanaya RamchandaniKwang Seok Ahn
Mar 16, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Min Hee YangKwang Seok Ahn
Aug 31, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Young Yun JungKwang Seok Ahn
Sep 6, 2020·Arthritis Research & Therapy·Yonghui DongJia Zheng
Dec 19, 2018·International Journal of Molecular Sciences·Jeong-Hyeon KoKwang Seok Ahn
Aug 25, 2019·International Journal of Molecular Sciences·Nand Kishor RoyAjaikumar B Kunnumakkara
Jul 10, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Clarissa Esmeralda HalimKwang Seok Ahn
Jul 2, 2020·Seminars in Cancer Biology·Elina KhatoonAjaikumar B Kunnumakkara
Dec 29, 2020·Frontiers in Pharmacology·Jinfeng ShiChaomei Fu
Apr 24, 2020·Seminars in Cancer Biology·Chakrabhavi Dhananjaya MohanKanchugarakoppal S Rangappa
Apr 4, 2021·International Journal of Molecular Sciences·Kumar RishabhAjaikumar B Kunnumakkara
May 20, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Young Yun JungKwang Seok Ahn

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
xenograft
flow cytometry
nuclear translocation

Software Mentioned

Image J

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.